Philogen S.p.A. IPO Pulled as Bayer Corporation Exits Cancer Pact

Pharma Times -- An eagerly-anticipated initial public offering by the Swiss-Italian biotech Philogen has been cancelled at the last minute after partner Bayer pulled out of their oncology collaboration.